Phaos Technology Holdings (Cayman) POAS
NYSE POAS
$0.16 0.00 (-2.02%)
At close: Aug 20, 2026 · 11:32 AM UTC

Phaos Technology Holdings (Cayman) (POAS) Work In Process (2024 - 2025)

Phaos Technology Holdings (Cayman)'s (POAS) quarterly Work In Process came in at $35443.0 in Q4 2025, down 10.64% on a QoQ basis from $39665.2 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Work In Process (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman) (POAS) has 2 years of Work In Process data on file, last reported at $35443.0 in Q4 2025.

  • Quarterly Work In Process changed N/A year-over-year to $35443.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $35443.0 (changed N/A YoY) and the FY2025 annual result came in at $40614.0, up 128.13% from the prior year.
  • Work In Process fell to $35443.0 in Q4 2025, from $39665.2 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $39665.2 in Q2 2025 to a low of $17803.2 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.51 Bn 194.91 Bn 7.27 Bn
2 Stryker 129.96 Bn 126.48 Bn 4.50 Bn
3 Medtronic 120.18 Bn 110.96 Bn 6.41 Bn
4 Boston Scientific 74.28 Bn 73.74 Bn 3.85 Bn
5 Edwards Lifesciences 52.75 Bn 48.50 Bn 1.35 Bn
6 Dexcom 34.67 Bn 32.73 Bn 830.00 Mn
7 GE HealthCare Technologies 34.23 Bn 32.12 Bn 2.18 Bn
8 Koninklijke Philips 26.46 Bn 23.14 Bn 4.55 Bn
9 Steris 23.30 Bn 22.82 Bn 684.20 Mn
10 Phaos Technology Holdings (Cayman) 4.12 Mn 4.08 Mn -

Historic Data

Download Data
DateValue
Oct 31, 2025 35,443.00
Apr 30, 2025 39,665.18
Apr 30, 2024 17,803.24